Bill > S06323

This bill amends the New York social services law to establish a new pricing mechanism for high-cost drugs, specifically those with a national average drug acquisition cost exceeding $670. Under the proposed legislation, pharmacies will be reimbursed at a rate no higher than 2.5% of the total drug cost, plus any authorized dispensing fees. This means that for extremely expensive medications, pharmacies will receive a very small percentage of the total drug price, which could help reduce overall healthcare costs. The provision is specifically targeted at drugs with high acquisition costs as defined by Medicare and Medicaid services, and the reimbursement rate includes reasonable administrative costs as determined by the state's health commissioner. The bill will take effect immediately but is designed to expire concurrently with the existing section of the social services law it modifies, ensuring that the change is integrated into the existing legal framework without creating a permanent standalone provision.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S6323